Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Evaluation of Drugs and Strategies for Treating Coronary Artery Ectasia: Update and Future Perspective
Alireza Amirzadegan Mahabadi
Alireza Amirzadegan Mahabadi

Associate Professor of Cardiology

Department Cardiology

School of Medicine

Tehran Heart Center

Tehran University of Medical Sciences

All Documents
1. An Interesting Case Series of Ticagrelor Induced Long Qtc, International Journal of Cardiology: Cardiovascular Risk and Prevention (2024)
2. Comparative Outcomes of Percutaneous Transvenous Mitral Commissurotomy Between Low and High Wilkins Score, Asian Cardiovascular and Thoracic Annals (2023)
3. Impact of Baseline Estimated Glomerular Filtration Rate Using Ckd-Epi Equation on Long-Term Prognosis of Stemi Patients: A Matter of Small Increments!, Critical Pathways in Cardiology (2022)
4. Prognostic Implications of Calculated Apo-Lipoprotein B in Patients With St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Outcome Is Tied to Lower Cut-Points, Clinical Cardiology (2021)
5. One-Month Clinical Outcomes of St-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention at a High-Volume Cardiac Tertiary Center: Routine Hours Versus Off-Hours, Critical Pathways in Cardiology (2020)
6. One-Year Outcome of Patients With Coronary Artery Ectasia Undergoing Percutaneous Coronary Intervention: Clinical Implications and Question Marks, Journal of Tehran University Heart Center (2020)
7. Short-Term Safety and Long-Term Benefits of Stent Postdilation After Primary Percutaneous Coronary Intervention: Results of a Cohort Study, Catheterization and Cardiovascular Interventions (2020)
8. The Impact of a Dedicated Coronavirus Disease 2019 Primary Angioplasty Protocol on Time Components Related to St-Segment Elevation Myocardial Infarction Management in a 24/7 Primary Percutaneous Coronary Intervention–Capable Hospital, Kardiologia Polska (2020)
9. Cha2ds2-Vasc Score As an Independent Predictor of Suboptimal Reperfusion and Short-Term Mortality After Primary Pci in Patients With Acute St Segment Elevation Myocardial Infarction, Medicina (Lithuania) (2019)
10. Coronary Slow Flow Phenomenon and Microalbuminuria: Is There Any Relationship?; [Koroner Yavas Akim Fenomeni Ve Mikroalbuminuri: Herhangi Bir Iliski Var Mi?], Turk Kardiyoloji Dernegi Arsivi (2019)
11. Does Invasive Treatment Increase the Long-Term Survival of St-Elevation Myocardial Infarction Patients With a History of Coronary Artery Bypass Graft Surgery?, Journal of Tehran University Heart Center (2019)
12. Effect of Age on Procedural Success, Complications, and Clinical Outcome From a Large Angioplasty Registry, Critical Pathways in Cardiology (2019)
13. Is Prolactin Serum Level and Coronary Artery Atherosclerosis Correlated in Postmenopausal Women? a Cross-Sectional Study, Turk Kardiyoloji Dernegi Arsivi (2019)
14. Single Long Stents Versus Overlapping Multiple Stents in the Management of Very Long Coronary Lesions: Comparisons of Procedures and Clinical Outcomes, Journal of Tehran University Heart Center (2019)
15. Strategies to Reduce the Door-To-Device Time in St-Elevation Myocardial Infarction Patients, Journal of Tehran University Heart Center (2019)
16. Time to Treatment and In-Hospital Major Adverse Cardiac Events Among Patients With St-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (Pci) According to the 24/7 Primary Pci Service Registry in Iran: Protocol for a Cross-Sectional Study, JMIR Research Protocols (2019)
17. Comparing Serum Level of Vitamin D3 in Patients With Isolated Coronary Artery Ectasia and Normal Coronary Artery Individuals, Archives of Iranian Medicine (2018)
18. Incidentally Detected Bifid Cardiac Apex in a Patient With Acute Myocardial Infarction: A Case Presentation and Brief Literature Review, Turk Kardiyoloji Dernegi Arsivi (2018)
19. Predictors of Long-Term Major Adverse Cardiac Events Following Percutaneous Coronary Intervention in the Elderly, Archives of Iranian Medicine (2018)
20. Predictors of Major Adverse Cardiac Events Following Elective Stenting of Large Coronary Arteries, Indian Heart Journal (2018)
21. Association of Serum Gamma-Glutamyltransferase and Premature Coronary Artery Disease, Netherlands Heart Journal (2017)
22. Biodegradable-Polymer Biolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study, Texas Heart Institute Journal (2016)
23. Comparing Clinical Outcomes for a Twelve-Month Trial of Zotarolimus- and Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Data From the Thcric Registry, Therapeutic Advances in Cardiovascular Disease (2016)
24. Comparison of 1-Year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein Iib/Iiia Inhibitors, Critical Pathways in Cardiology (2016)
25. The Impact of Cytochrome P450 2C19 Polymorphism on the Occurrence of One-Year In-Stent Restenosis in Patients Who Underwent Percutaneous Coronary Intervention: A Case-Match Study, Anadolu Kardiyoloji Dergisi (2015)